Di- Cal Pharma Private Limited - Company Profile

It is a chemicals and materials private limited company based in Chhatral, Gujarat, India, established in 2008.
2008 Chhatral, Gujarat, India Active
Last Updated:
Access Report
About Di- Cal Pharma Private Limited

Di- Cal Pharma Private Limited, a active private limited company, was established on 06 November 2008 in Chhatral, Gujarat, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24110GJ2008PTC055370. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Its leadership includes Ashokbhai Vijaysinh Barot (Director), Sangeeta Mukur Barot (Director), Sharadbhai Prahaldbhai Patel (Director). Past directors included Dhananjay Ashokkumar Barot, Asmitaben Premalkumar Patel, Premal Babubhai Patel. It holds no open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Block No. 1139, Opp. G.E.B, Kadi Road Chhatral, Taluka - Kalol, Chhatral, Gujarat, 382729.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110GJ2008PTC055370

  • Registration Number

    055370

  • Incorporation Date

    06 November 2008

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 17 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.38 Cr
  • Revenue Growth **** -97.23%
  • Profit Growth **** 72.80%
  • Ebitda **** -1619.21%
  • Net Worth -22.03%
  • Total Assets -60.01%
Company report

Di- Cal Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Di- Cal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Di- Cal Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashokbhai Vijaysinh Barot Director 06 Nov 2008 Current
Sangeeta Mukur Barot Director 06 Nov 2008 Current
Sharadbhai Prahaldbhai Patel Director 06 Nov 2008 Current
Asmitaben Premalkumar Patel Director 15 Feb 2020 Current
Mukurdhvaj Yogeshkumar Barot Director 06 Nov 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Sep 2019 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past
Pramod Abcsdd Director 13 Dec 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Di- Cal Pharma.

Di- Cal Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.23% decrease. The company also saw a substantial improvement in profitability, with a 72.8% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.03%.

Di- Cal Pharma revenue growth over time
Di- Cal Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -97.23%
*******
*******
*******
*******
Revenue from Operations
*******
 -100.00%
*******
*******
*******
*******
Total Assets
*******
 -60.01%
*******
*******
*******
*******
Profit or Loss
*******
 72.80%
*******
*******
*******
*******
Net Worth
*******
 -22.03%
*******
*******
*******
*******
EBITDA
*******
 -1619.21%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Di- Cal Pharma?

Unlock access to Di- Cal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹13,800,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 1.38 Cr
Latest Charge Details
Date Lender Amount Status
27 Jun 2009 Bank Of India ₹1.38 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Di- Cal Pharma?

Unlock and access historical data on people associated with Di- Cal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Di- Cal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Di- Cal Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Di- Cal Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Di- Cal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Di- Cal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Charges

    Progress on A charge registered on 27 Jun 2009 via Charge ID 10167193 with Bank Of India was fully satisfied on 17 Jan 2023. was documented.

  • Director Appointment

    Asmitaben Premalkumar Patel was appointed as a Director was appointed as a Director on 15 Feb 2020 & has been associated with this company since 6 years 26 days . was recorded as a recent event.

  • Charges

    A charge with Bank Of India amounted to Rs. 13.80 M with Charge ID 10167193 was registered on 27 Jun 2009. was recorded as a recent event.

  • Director Appointment

    The activity Ashokbhai Vijaysinh Barot was appointed as a Director was appointed as a Director on 06 Nov 2008 & has been associated with this company since 17 years 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Di- Cal Pharma Private Limited?

The CIN of Di- Cal Pharma Private Limited is U24110GJ2008PTC055370.

Where is Di- Cal Pharma Private Limited headquartered?

Di- Cal Pharma Private Limited is headquartered at Block No. 1139, Opp. G.E.B, Kadi Road Chhatral, Taluka - Kalol, Chhatral, Gujarat, 382729.

When was Di- Cal Pharma Private Limited incorporated?

Di- Cal Pharma Private Limited was incorporated on 06 November 2008.

Who are the current directors of Di- Cal Pharma Private Limited?

The current directors of Di- Cal Pharma Private Limited are

What is the primary industry of Di- Cal Pharma Private Limited?

The primary industry of Di- Cal Pharma Private Limited is Manufacturing.

Is Di- Cal Pharma Private Limited a listed company?

Di- Cal Pharma Private Limited is unlisted.

What is the capital structure of Di- Cal Pharma Private Limited?

The authorized capital of Di- Cal Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Di- Cal Pharma Private Limited?

The compliance status of Di- Cal Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available